Search at Vanderbilt-Ingram Cancer Center

1193 results found

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Relevance: 1

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Relevance: 1

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

Relevance: 1

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Relevance: 1

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Relevance: 1

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

Relevance: 1

Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

Relevance: 1

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Relevance: 1

A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

Relevance: 1

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Relevance: 1